Correlation Between Vitrolife and Mendus AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vitrolife and Mendus AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vitrolife and Mendus AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vitrolife AB and Mendus AB, you can compare the effects of market volatilities on Vitrolife and Mendus AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vitrolife with a short position of Mendus AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vitrolife and Mendus AB.

Diversification Opportunities for Vitrolife and Mendus AB

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between Vitrolife and Mendus is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Vitrolife AB and Mendus AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mendus AB and Vitrolife is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vitrolife AB are associated (or correlated) with Mendus AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mendus AB has no effect on the direction of Vitrolife i.e., Vitrolife and Mendus AB go up and down completely randomly.

Pair Corralation between Vitrolife and Mendus AB

Assuming the 90 days trading horizon Vitrolife AB is expected to under-perform the Mendus AB. But the stock apears to be less risky and, when comparing its historical volatility, Vitrolife AB is 2.2 times less risky than Mendus AB. The stock trades about -0.1 of its potential returns per unit of risk. The Mendus AB is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  787.00  in Mendus AB on September 13, 2024 and sell it today you would earn a total of  112.00  from holding Mendus AB or generate 14.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Vitrolife AB  vs.  Mendus AB

 Performance 
       Timeline  
Vitrolife AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vitrolife AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Mendus AB 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Mendus AB are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Mendus AB unveiled solid returns over the last few months and may actually be approaching a breakup point.

Vitrolife and Mendus AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vitrolife and Mendus AB

The main advantage of trading using opposite Vitrolife and Mendus AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vitrolife position performs unexpectedly, Mendus AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mendus AB will offset losses from the drop in Mendus AB's long position.
The idea behind Vitrolife AB and Mendus AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets